News
- Author:
- Alan P. Lyss, MD
Publish date: May 21, 2021
Dr. Alan Lyss reviews data on HER2-targeted therapies in breast cancer.
Article
- Author:
- Alan P. Lyss, MD
Publish date: May 3, 2021
Dr. Alan Lyss describes a recent presentation on the role of social media in oncology.
Article
- Author:
- Alan P. Lyss, MD
Publish date: April 23, 2021
Dr. Alan Lyss reviews updated results with atezolizumab in locally advanced or metastatic urothelial carcinoma.
Article
- Author:
- Alan P. Lyss, MD
Publish date: April 16, 2021
Dr. Alan Lyss reviews research suggesting that an antibiotic can improve the efficacy of radiotherapy.
Article
- Author:
- Alan P. Lyss, MD
Publish date: April 9, 2021
Dr. Alan Lyss explores two studies of patients with steroid-resistant or refractory pneumonitis resulting from im...
Article
- Author:
- Alan P. Lyss, MD
Publish date: March 12, 2021
Dr. Alan Lyss explores mCODE, a project designed to improve the sharing of data from cancer patients.
Article
- Author:
- Alan P. Lyss, MD
Publish date: March 5, 2021
Dr. Alan Lyss reviews a study that revealed trends in genetic testing over time.
Opinion
- Author:
- Alan P. Lyss, MD
Publish date: February 26, 2021
EV is an antibody-drug conjugate directed against nectin-4, an immunoglobulin-like cell adhesion molecule that is...
Article
- Author:
- Alan P. Lyss, MD
Publish date: February 18, 2021
A survey suggests the pandemic has impacted rural and urban cancer patients somewhat differently.
Article
- Author:
- Alan P. Lyss, MD
Publish date: February 16, 2021
Dr. Alan Lyss reviews studies using artificial intelligence to predict lung cancer risk and outcomes.
Article
- Author:
- Alan P. Lyss, MD
Publish date: January 26, 2021
Circulating tumor DNA testing bested carcinoembryonic antigen testing in a study of patients with colorectal canc...
Article
- Author:
- Alan P. Lyss, MD
Publish date: January 14, 2021
Dr. Alan P. Lyss describes RSClin, a tool for estimating the risk of distant relapse in breast cancer.
Article
- Author:
- Alan P. Lyss, MD
Publish date: December 24, 2020
Dr. Alan Lyss reviews results of the DART trial and highlights the value of clinical trials for rare cancers.
Article
- Author:
- Alan P. Lyss, MD
Publish date: December 10, 2020
Dr. Alan Lyss examines how new endpoints, novel study design, and other methods might better quantify the effects...
Article
- Author:
- Alan P. Lyss, MD
Publish date: November 17, 2020
Dr. Alan Lyss discusses the use of telehealth for palliative cancer care, including results from the REACH PC trial.
